BAX inhibition either using peptide-based approaches or gene therapy could prevent the neuronal cell death induced by oligomeric Aβ.450 Thus, in the context of AD, selective BAX inhibitors could be promising to sustain the survival of neurons and thus potentially delay cognitive decline.451. Here, BAX is linked to Alzheimer disease.